• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Nature's Sunshine Products Inc. (Amendment)

    1/31/24 11:56:05 AM ET
    $NATR
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $NATR alert in real time by email
    SC 13G/A 1 form_sc13ga-natures.htm


    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    WASHINGTON, D.C. 20549
    SCHEDULE 13G
    (Amendment No. 4)
    (Rule 13d-102)
    INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO
    RULES 13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED
    PURSUANT TO RULE 13d-2(b)
    Nature’s Sunshine Products, Inc.
    (Name of Issuer)
    Common Stock, no par value per share
    (Title of Class of Securities)
    639027101
    (CUSIP Number)
    December 31, 2023
    (Date of Event Which Requires Filing of this Statement)
    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
    ☒ Rule 13d-1(b)
    ☒ Rule 13d-1(c)
    ☐ Rule 13d-1(d)


    CUSIP No.  639027101
     
     
     
     
     
      1 
     
    NAME OF REPORTING PERSONS
     
    Prescott Group Capital Management, L.L.C.
      2
     
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
    (a)  ☐        (b)  ☐
     
      3
     
    SEC USE ONLY
     
     
      4
     
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
    State of Oklahoma
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON
    WITH
     
     5 
     
              SOLE VOTING POWER
     
               1,783,097
     6
     
              SHARED VOTING POWER
     
               0
     7
     
              SOLE DISPOSITIVE POWER
     
              1,783,097
     8
     
              SHARED DISPOSITIVE POWER
     
              0
    9
     
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
    1,783,097
    10
     
    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
     
    ☐
    11
     
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
     
    9.4%**
    12
     
    TYPE OF REPORTING PERSON*
     
    IA

    *
    SEE INSTRUCTIONS BEFORE FILLING OUT
    **
    SEE ITEM 4.
     


    CUSIP No. 639027101
      
     
      
     
     
      1 
     
    NAME OF REPORTING PERSONS
     
    Prescott Group Aggressive Small Cap, L.P.
      2
     
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
    (a)  ☐        (b)  ☐
     
      3
     
    SEC USE ONLY
     
     
      4
     
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
    State of Oklahoma
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON
    WITH
     
     5
      
                SOLE VOTING POWER
     
                 0
     6
      
                SHARED VOTING POWER
     
                1,781,529
     7
      
                SOLE DISPOSITIVE POWER
     
                0
     8
      
                SHARED DISPOSITIVE POWER
     
                1,781,529
    9
     
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
    1,781,529
    10
     
    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
     
    ☐
    11
     
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
     
    9.3%**
    12
     
    TYPE OF REPORTING PERSON*
     
    PN

    *
    SEE INSTRUCTIONS BEFORE FILLING OUT
    **
    SEE ITEM 4.
     


    CUSIP No. 639027101
      
     
      
     
     
      1 
     
    NAME OF REPORTING PERSONS
     
    Prescott Group Aggressive Small Cap II, L.P.
      2
     
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
    (a)  ☐        (b)  ☐
     
      3
     
    SEC USE ONLY
     
     
      4
     
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
    State of Oklahoma
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON
    WITH
     
     5
      
               SOLE VOTING POWER
     
               0
     6
      
               SHARED VOTING POWER
     
               1,781,529
     7
      
               SOLE DISPOSITIVE POWER
     
               0
     8
      
               SHARED DISPOSITIVE POWER
     
               1,781,529
    9
     
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
    1,781,529
    10
     
    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
     
    ☐
    11
     
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
     
    9.3%**
    12
     
    TYPE OF REPORTING PERSON*
     
    PN

    *
    SEE INSTRUCTIONS BEFORE FILLING OUT
    **
    SEE ITEM 4.
     


    CUSIP No. 639027101
      
     
      
     
     
      1 
     
    NAME OF REPORTING PERSONS
     
    Prescott Group Aggressive Small Cap Master Fund, G.P.
      2
     
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
    (a)  ☐        (b)  ☐
     
      3
     
    SEC USE ONLY
     
     
      4
     
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
    State of Oklahoma
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON
    WITH
     
     5
     
              SOLE VOTING POWER
     
              0
     6
     
              SHARED VOTING POWER
     
              1,781,529
     7
     
              SOLE DISPOSITIVE POWER
     
              0
     8
     
              SHARED DISPOSITIVE POWER
     
              1,781,529
    9
     
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
    1,781,529
    10
     
    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
     
    ☐
    11
     
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
     
    9.3%**
    12
     
    TYPE OF REPORTING PERSON*
     
    PN
     
    *
     
    SEE INSTRUCTIONS BEFORE FILLING OUT
    **
    SEE ITEM 4.



     
    CUSIP No. 639027101
      
     
      
     
     
      1 
     
    NAME OF REPORTING PERSONS
     
    Phil Frohlich
      2
     
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
    (a)  ☐        (b)  ☐
     
      3
     
    SEC USE ONLY
     
     
      4
     
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
    U.S. Citizen
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON
    WITH
     
     5
      
               SOLE VOTING POWER
     
                1,783,097
     6
      
               SHARED VOTING POWER
     
                0
     7
      
               SOLE DISPOSITIVE POWER
     
               1,783,097
     8
      
               SHARED DISPOSITIVE POWER
     
               0
    9
     
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
    1,783,097
    10
     
    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
     
    ☐
    11
     
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
     
    9.4%**
    12
     
    TYPE OF REPORTING PERSON*
     
    IN, HC

    *
    SEE INSTRUCTIONS BEFORE FILLING OUT
    **
    SEE ITEM 4.
     

    AMENDMENT NO. 4 TO SCHEDULE 13G
    This Amendment No. 4 (the “Amendment”) to the Schedule 13G (the “Schedule 13G”) is being filed on behalf of Prescott Group Capital Management, L.L.C., an Oklahoma limited liability company (“Prescott Capital”), Prescott Group Aggressive Small Cap, L.P., an Oklahoma limited partnership (“Prescott Small Cap”), Prescott Group Aggressive Small Cap II, L.P., an Oklahoma limited partnership (“Prescott Small Cap II”, and, together with Prescott Small Cap, the “Small Cap Funds”), Prescott Group Aggressive Small Cap Master Fund, G.P., an Oklahoma general partnership (“Master Fund”) and Mr. Phil Frohlich, the principal of Prescott Capital, relating to the Common Stock, no par value per share (the “Common Stock”), of Nature’s Sunshine Products, Inc., a Utah corporation (the “Issuer”).
    This Amendment relates to shares of Common Stock of the Issuer held in the account of the (i) Master Fund, of which the Small Cap Funds are general partners, and (ii) a partnership of which Prescott Capital serves as the general partner (the “Account”). Prescott Capital serves as the general partner and investment manager of the Small Cap Funds and may direct the Small Cap Funds, the general partners of the Master Fund, to direct the vote and disposition of the 1,781,529 shares of Common Stock held by the Master Fund as of December 31, 2023. As the general partner of the Account, Prescott Capital may direct the vote and disposition of the 1,568 shares of Common Stock held by the Account as of December 31, 2023.  As the principal of Prescott Capital, Mr. Frohlich may direct the vote and disposition of the 1,781,529 shares of Common Stock held by the Master Fund as of December 31, 2023 and the 1,568 shares of Common Stock held by the Account as of December 31, 2023.
    This Amendment amends and restates the Schedule 13G as follows.

    Item 1(a)
     Name of Issuer.
    Nature’s Sunshine Products, Inc. (the “Issuer”)
     
    Item 1(b)
     Address of Issuer’s Principal Executive Offices.
    2901 Bluegrass Blvd., Suite 100
    Lehi, Utah 84043

    Item 2(a)
     Name of Person Filing.
    Prescott Group Capital Management, L.L.C. (“Prescott Capital”), Prescott Group Aggressive Small Cap, L.P. (“Prescott Small Cap”), Prescott Group Aggressive Small Cap II, L.P. (“Prescott Small Cap II” and, together with Prescott Small Cap, the “Small Cap Funds”), Prescott Group Aggressive Small Cap Master Fund, G.P. (“Master Fund”) and Mr. Phil Frohlich.

    Item 2(b)
     Address of Principal Business Office, or, if none, Residence.
    1924 South Utica, Suite 1120
    Tulsa, Oklahoma 74104

    Item 2(c)
     Citizenship or Place of Organization.

    Prescott Capital is an Oklahoma limited liability company. The Small Cap Funds are Oklahoma limited partnerships. The Master Fund is an Oklahoma general partnership.  Mr. Phil Frohlich is the principal of Prescott Capital and is a U.S. citizen.

    Item 2(d)
     Title of Class of Securities.
    Common Stock, no par value per share (the “Common Stock”).

    Item 2(e)
     CUSIP Number.
    639027101
     


    Item 3
      Reporting Person.
    If this statement is filed pursuant to Rule 13d-1(b), or 13d-2(b), check whether the person filing is a:
     
     
     
     
     
     
     
     
     
                
     
    (a)
     
    ☐
      
    Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).
     
     
     
     
     
     
     
     
    (b)
     
    ☐
      
    Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).
     
     
     
     
     
     
     
     
    (c)
     
    ☐
      
    Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).
     
     
     
     
     
     
     
     
    (d)
     
    ☐
      
    Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).
     
     
     
     
     
     
     
     
    (e)
     
    ☒
      
    An investment advisor in accordance with §240.13d-1(b)(1)(ii)(E).
     
     
     
     
     
     
     
     
    (f)
     
    ☐
      
    An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F).
     
     
     
     
     
     
     
     
    (g)
     
    ☒
      
    A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G).
     
     
     
     
     
     
     
     
    (h)
     
    ☐
      
    A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813).
     
     
     
     
     
     
     
     
    (i)
     
    ☐
      
    A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3).
     
     
     
     
     
     
     
     
    (j)
     
    ☐
      
    A non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J).
     
     
     
     
     
     
     
     
     
     
     
    (k)
     
    ☐
     
    Group, in accordance with §240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J), please specify the type of institution: ____.
     
     
    Item 4
     Ownership.

     
    (a)
    Each of Prescott Capital and Mr. Phil Frohlich are the beneficial owners of 1,783,097 shares of Common Stock as of December 31, 2023.  Each of the Small Cap Funds and the Master Fund are the beneficial owners of 1,781,529 shares of Common Stock as of December 31, 2023.
     
     
    (b)
    Each of Prescott Capital and Mr. Phil Frohlich are the beneficial owners of 9.4% of the outstanding shares of Common Stock as of December 31, 2023.  This percentage is determined by dividing 1,783,097 by 19,075,041, the number of shares of Common Stock outstanding as of October 20, 2023, as reported in the Issuer’s Form 10-Q filed with the Securities and Exchange Commission on November 7, 2023.  Each of the Small Cap Funds and the Master Fund are the beneficial owners of 9.3% of the outstanding shares of Common Stock as of December 31, 2023.  This percentage is determined by dividing 1,781,529 by 19,075,041, the number of shares of Common Stock outstanding as of October 20, 2023, as reported in the Issuer’s Form 10-Q filed with the Securities and Exchange Commission on November 7, 2023.
     
     
    (c)
    Prescott Capital, as the general partner and investment manager of the Small Cap Funds, the general partners of the Master Fund, may direct the Small Cap Funds to direct the voting and disposition of the 1,781,529 shares of Common Stock held by the Master Fund as of December 31, 2023. As the principal of Prescott Capital, Mr. Phil Frohlich may direct the voting and disposition of the 1,781,529 shares of Common Stock held by the Master Fund as of December 31, 2023.  As the general partner of the Account, Prescott Capital may direct the vote and disposition of the 1,568 shares of Common Stock held by the Account as of December 31, 2023.  As the principal of Prescott Capital, Mr. Phil Frohlich may direct the voting and disposition of the 1,568 shares of Common Stock held by the Account as of December 31, 2023.
     
    Item 5
      Ownership of Five Percent or Less of a Class.
    Inapplicable.
     
    Item 6
      Ownership of More Than Five Percent on Behalf of Another Person.
    Inapplicable.
     


    Item 7
     Identification and Classification of the Subsidiary which Acquired the Security Being Reported On by the Parent Holding Company.
    Inapplicable.
     
    Item 8
      Identification and Classification of Members of the Group.
    Inapplicable.
     
    Item 9
      Notice of Dissolution of Group.
    Inapplicable.
     
    Item 10
     Certification.
    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

     

    SIGNATURE
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
    Date: January 31, 2024


     
     
     
     
     
    Prescott Group Capital Management, L.L.C.
     
     
     
     
    By:
     
    /s/ Phil Frohlich
     
     
     
    PHIL FROHLICH, Managing Member
     
     
    Prescott Group Aggressive Small Cap, L.P.
     
     
     
     
    By:
     
    Prescott Group Capital Management, L.L.C.,
    its general partner
     
     
     
     
    By:
     
    /s/ Phil Frohlich
     
     
     
    PHIL FROHLICH, Managing Member
     
     
    Prescott Group Aggressive Small Cap II, L.P.
     
     
     
     
    By:
     
    Prescott Group Capital Management, L.L.C.,
    its general partner
     
     
     
     
     
    By:
     
    /s/ Phil Frohlich
     
     
     
    PHIL FROHLICH, Managing Member
     
     
    Prescott Group Aggressive Small Cap Master Fund, G.P.
     
     
     
     
    By:
     
    Prescott Group Aggressive Small Cap, L.P.,
    general partner
     
     
     
     
     
    By:
     
    Prescott Group Aggressive Small Cap II, L.P.,
    general partner
     
     
     
     
     
    By:
     
    Prescott Group Capital Management, L.L.C.,
    general partner
     
     
     
     
     
    By:
     
    /s/ Phil Frohlich
     
     
     
    PHIL FROHLICH, Managing Member
     
     
     
     
      /s/ Phil Frohlich
    Phil Frohlich


     


    Get the next $NATR alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $NATR

    DatePrice TargetRatingAnalyst
    5/7/2025$19.00Buy
    DA Davidson
    9/13/2024$18.00Buy
    Canaccord Genuity
    3/9/2022$24.00 → $24.50Buy
    DA Davidson
    11/5/2021$22.00 → $24.00Buy
    DA Davidson
    10/15/2021$22.00Buy
    DA Davidson
    More analyst ratings

    $NATR
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Nature's Sunshine Reports Strong First Quarter 2025 Results

      LEHI, Utah, May 06, 2025 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (NASDAQ:NATR) ("Nature's Sunshine"), a leading manufacturer of high-quality herbal and nutritional supplements, reported financial results for the first quarter ended March 31, 2025. First Quarter 2025 Financial Summary vs. Same Year-Ago Quarter Net sales were up 2% to $113.2 million compared to $111.0 million (up 5% in constant currency).GAAP net income attributable to common shareholders was up 104% to $4.7 million, or $0.25 per diluted common share, compared to $2.3 million, or $0.12 per diluted common share.Adjusted EBITDA was up 20% to $11.0 million compared to $9.2 million. Capital Allocation Na

      5/6/25 4:05:00 PM ET
      $NATR
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Nature's Sunshine Appoints Heidi Wissmiller as Chairman of the Board

      LEHI, Utah, May 05, 2025 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (NASDAQ:NATR), a leading natural health and wellness company of high-quality herbal and nutritional products, today announced the appointment of Heidi Wissmiller as Chairman of the Board of Directors, effective April 30, 2025. She succeeds Richard D. Moss, who has retired after serving as a Director since 2018 and Chairman since 2022. Ms. Wissmiller has served on the Board of Nature's Sunshine since 2020. Over the course of her tenure, she has chaired the Governance and Risk Management Committees. As Chief Growth Officer at Rodan + Fields ("R+F"), the leading skincare brand in North America, Ms. Wissmiller led

      5/5/25 8:00:00 AM ET
      $NATR
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Nature's Sunshine Wins Two Stevie® Awards in the 2025 American Business Awards®

      LEHI, Utah, April 24, 2025 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (NASDAQ:NATR), a leading manufacturer of high-quality herbal and nutritional supplements, today announced it has been recognized with two prestigious Stevie® Awards in the 23rd Annual American Business Awards®. Nature's Sunshine received a Gold Stevie® Award for its 2023 Impact Report, which detailed the Company's achievements and progress in responsible business practices and sustainability. Additionally, the Company earned a Silver Stevie® Award for Achievement in Product Innovation for its new Chlorophyll Detoxifying Stick Packs. "We are deeply honored to be recognized by the American Business Awards," sai

      4/24/25 1:52:06 PM ET
      $NATR
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $NATR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Fasching Steven J. was granted 8,000 shares, increasing direct ownership by 279% to 10,869 units (SEC Form 4)

      4 - NATURES SUNSHINE PRODUCTS INC (0000275053) (Issuer)

      5/7/25 1:25:23 PM ET
      $NATR
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Director Straus Robert D was granted 8,000 shares, increasing direct ownership by 18% to 52,014 units (SEC Form 4)

      4 - NATURES SUNSHINE PRODUCTS INC (0000275053) (Issuer)

      5/6/25 3:42:40 PM ET
      $NATR
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Director Roering Tess was granted 8,000 shares, increasing direct ownership by 36% to 29,927 units (SEC Form 4)

      4 - NATURES SUNSHINE PRODUCTS INC (0000275053) (Issuer)

      5/6/25 3:42:30 PM ET
      $NATR
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $NATR
    Financials

    Live finance-specific insights

    See more
    • Nature's Sunshine Reports Strong First Quarter 2025 Results

      LEHI, Utah, May 06, 2025 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (NASDAQ:NATR) ("Nature's Sunshine"), a leading manufacturer of high-quality herbal and nutritional supplements, reported financial results for the first quarter ended March 31, 2025. First Quarter 2025 Financial Summary vs. Same Year-Ago Quarter Net sales were up 2% to $113.2 million compared to $111.0 million (up 5% in constant currency).GAAP net income attributable to common shareholders was up 104% to $4.7 million, or $0.25 per diluted common share, compared to $2.3 million, or $0.12 per diluted common share.Adjusted EBITDA was up 20% to $11.0 million compared to $9.2 million. Capital Allocation Na

      5/6/25 4:05:00 PM ET
      $NATR
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Nature's Sunshine Sets First Quarter 2025 Conference Call for Tuesday, May 6, 2025, at 5:00 p.m. ET

      LEHI, Utah, April 22, 2025 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (NASDAQ:NATR) (Nature's Sunshine), a leading manufacturer of high-quality herbal and nutritional supplements, will conduct a conference call on Tuesday, May 6, 2025, at 5:00 p.m. Eastern time (3:00 p.m. Mountain time) to discuss its financial results for the first quarter ended March 31, 2025. The company will report its financial results in a press release prior to the conference call. Nature's Sunshine CEO Terrence Moorehead and CFO Shane Jones will host the conference call, followed by a question and answer period. Date: Tuesday, May 6, 2025Time: 5:00 p.m. Eastern time (3:00 p.m. Mountain time)Toll-free di

      4/22/25 4:04:59 PM ET
      $NATR
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Nature's Sunshine Reports Fourth Quarter and Full Year 2024 Financial Results

      LEHI, Utah, March 11, 2025 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (NASDAQ:NATR) ("Nature's Sunshine" and/or the "Company"), a leading manufacturer of high-quality herbal and nutritional supplements, reported financial results for the fourth quarter and full year ended December 31, 2024. Fourth Quarter 2024 Financial Summary vs. Same Year-Ago Quarter Net sales were up 8.5% to $118.2 million compared to $108.9 million (up 10.0% in constant currency).GAAP net loss attributable to common shareholders of $0.3 million, or $(0.02) per diluted share, compared to net income of $9.0 million, or $0.46 per diluted share.Adjusted EBITDA up 6% to $10.3 million com

      3/11/25 4:05:00 PM ET
      $NATR
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $NATR
    Leadership Updates

    Live Leadership Updates

    See more
    • Nature's Sunshine Appoints Heidi Wissmiller as Chairman of the Board

      LEHI, Utah, May 05, 2025 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (NASDAQ:NATR), a leading natural health and wellness company of high-quality herbal and nutritional products, today announced the appointment of Heidi Wissmiller as Chairman of the Board of Directors, effective April 30, 2025. She succeeds Richard D. Moss, who has retired after serving as a Director since 2018 and Chairman since 2022. Ms. Wissmiller has served on the Board of Nature's Sunshine since 2020. Over the course of her tenure, she has chaired the Governance and Risk Management Committees. As Chief Growth Officer at Rodan + Fields ("R+F"), the leading skincare brand in North America, Ms. Wissmiller led

      5/5/25 8:00:00 AM ET
      $NATR
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Nature's Sunshine Appoints Katie A. May to Board of Directors

      LEHI, Utah, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (Nature's Sunshine) (NASDAQ:NATR), a leading manufacturer of high-quality herbal and nutritional supplements, today announced the appointment of Ms. Katie A. May to its board of directors effective January 30, 2025. Nature's Sunshine's board will now consist of ten directors with nine serving as independent directors. "Katie brings significant experience scaling and leading high-growth B2C, ecommerce and logistics companies," said Richard D. Moss, Chairman of the Board of Nature's Sunshine. "Her deep understanding of the full ecommerce lifecycle will strengthen and enhance our digital capabilities and drive s

      2/5/25 4:05:00 PM ET
      $NATR
      $PBI
      $STMP
      Biotechnology: Pharmaceutical Preparations
      Health Care
      Office Equipment/Supplies/Services
      Miscellaneous
    • Nature's Sunshine Appoints Steven Fasching to Board of Directors

      LEHI, Utah, Nov. 11, 2024 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (Nature's Sunshine) (NASDAQ:NATR), a leading manufacturer of high-quality herbal and nutritional supplements, today announced the appointment of Mr. Steven Fasching to its board of directors, effective November 6, 2024. Nature's Sunshine's board will now consist of nine directors with eight serving as independent directors. "We are delighted to welcome Steve to our expanded board of directors," said Richard D. Moss, Chairman of the Board for Nature's Sunshine. "He brings significant financial acumen and public company experience from well-known consumer brands and will be a valuable addition to our board. Ste

      11/11/24 4:05:00 PM ET
      $DECK
      $NATR
      Shoe Manufacturing
      Consumer Discretionary
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $NATR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Nature's Sunshine Products Inc. (Amendment)

      SC 13G/A - NATURES SUNSHINE PRODUCTS INC (0000275053) (Subject)

      2/12/24 10:37:49 AM ET
      $NATR
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form SC 13G/A filed by Nature's Sunshine Products Inc. (Amendment)

      SC 13G/A - NATURES SUNSHINE PRODUCTS INC (0000275053) (Subject)

      1/31/24 11:56:05 AM ET
      $NATR
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form SC 13G/A filed by Nature's Sunshine Products Inc. (Amendment)

      SC 13G/A - NATURES SUNSHINE PRODUCTS INC (0000275053) (Subject)

      2/13/23 2:42:04 PM ET
      $NATR
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $NATR
    SEC Filings

    See more
    • SEC Form 10-Q filed by Nature's Sunshine Products Inc.

      10-Q - NATURES SUNSHINE PRODUCTS INC (0000275053) (Filer)

      5/6/25 5:10:24 PM ET
      $NATR
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Nature's Sunshine Products Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

      8-K - NATURES SUNSHINE PRODUCTS INC (0000275053) (Filer)

      5/6/25 4:38:55 PM ET
      $NATR
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form DEF 14A filed by Nature's Sunshine Products Inc.

      DEF 14A - NATURES SUNSHINE PRODUCTS INC (0000275053) (Filer)

      3/20/25 10:09:21 AM ET
      $NATR
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $NATR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • DA Davidson resumed coverage on Nature's Sunshine with a new price target

      DA Davidson resumed coverage of Nature's Sunshine with a rating of Buy and set a new price target of $19.00

      5/7/25 8:37:48 AM ET
      $NATR
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Canaccord Genuity initiated coverage on Nature's Sunshine with a new price target

      Canaccord Genuity initiated coverage of Nature's Sunshine with a rating of Buy and set a new price target of $18.00

      9/13/24 7:38:59 AM ET
      $NATR
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • DA Davidson reiterated coverage on Natures Sunshine Products with a new price target

      DA Davidson reiterated coverage of Natures Sunshine Products with a rating of Buy and set a new price target of $24.50 from $24.00 previously

      3/9/22 9:23:08 AM ET
      $NATR
      Biotechnology: Pharmaceutical Preparations
      Health Care